NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users
About this document
- Layer
- attachment: a document a meeting packet links to
- Type as titled
- publication (kind from doc_type)
- File
- 3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
- Cases
About: Jaime Bermudez (case)
Overall Drug Positivity Excluding Alcohol and Cannabinoids. As can be seen in the above tables, alcohol and cannabinoids (active THC) are by far the most prevalent drugs. In order to examine the overall prevalence of other drugs without consideration of alcohol and cannabinoids, Table 22 provides counts and percentages for trauma center, ME, and total driver cases positive for drugs when alcohol and/or cannabis data were excluded from the analyses. As shown in the table, 23.7% of the trauma center and 31.4% of the medical examiner driver cases tested positive for at least one category of drugs other than alcohol and cannabis. Overall, 5.6% of the trauma center and 9.0% of the medical examiner driver cases tested positive for two or more categories of drugs other than alcohol and cannabis.
Table 22. Driver Drug Positivity Excluding Alcohol and Cannabinoids by Case Source
| Trauma Center (n =4,243) |
Medical Examiner (n =555) |
Total (N =4,798) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | 95% CI | n | % | 95% CI | n | % | 95% CI | |
| Positive for at Least 1 Drug Category Other Than Alcohol and Cannabinoids | 1,004 | 23.7 | [22.4, 25.0] | 174 | 31.4 | [27.6, 35.3] | 1,178 | 24.6 | [23.3, 25.8] |
| Positive for 2 or More Drug Categories Other Than Alcohol and Cannabinoids | 239 | 5.6 | [5.0, 6.4] | 50 | 9.0 | [6.8, 11.6] | 289 | 6.0 | [5.4, 6.7] |
Summary of Results
This study analyzed blood specimens from a large number of seriously or fatally injured roadway users from selected trauma centers and MEs in the United States to understand more about drug prevalence among these populations. Seven trauma centers and four MEs' offices participated in the study by providing over 7,500 suspected roadway user specimens for independent toxicological analysis. The specimens were made available as part of normal treatment or autopsy procedures shortly after crashes that allowed for the best opportunity to determine whether drugs were likely in the people's systems at the time of the crashes in which they were injured or killed.
Of the specimens provided, 7,279 were confirmed to be adult roadway users of interest (drivers, pedestrians, bicyclists, and passengers) for whom enough blood was made available within 6 hours of the crash event for complete toxicological analysis. The descriptive results showed overall drug positivity (i.e., positive for alcohol or any other drug on the study panel) was 55.8% for the entire study sample combined across all trauma centers and MEs. For trauma center cases, 54.1% of all roadway users were positive for any drug compared to 67.7% for all ME cases (see Table 7).
Breaking out the prevalence results by position in crash (e.g., driver, pedestrian, and bicyclist) showed that drug prevalence was relatively high for each group. The results in this report focused on drug prevalence for drivers (including motorcycle operators) combined across the seven trauma centers (n = 4,243) for the entire study period, and separately for drivers combined across the four participating ME offices (n = 555). The study found that 54.4% of the trauma center driver cases tested positive for one or more drugs on the study's panel with cannabinoids being the most prevalent (25.0%) followed by alcohol (21.6%). Stimulants (9.8%), opioids (8.6%), and sedatives (7.5%) were also frequently detected among trauma center cases. The
39
Keys: ← → or j k turn pages; / finds.